The Power of 3-7-11 and the Grand Super Cycle: How We Saw the Bullish Turn in April 2025 Back on April 9, 2025, while World Indices were dropping sharply and global sentiment had turned overwhelmingly bearish, we published an article that challenged the fear-driven narrative. We explained why selling was not the right approach and […]
-
Gold Miners ETF (GDX) Develops Elliott Wave Bullish Sequence
Read MoreGold Miners ETF (GDX) soon will open bullish sequence favoring more upside. This article and video look at the Elliott Wave path.
-
Real Estate Trust ($MAA) Should See More Downside. But Why?
Read MoreHello Everyone! In today’s article, we will look at the Elliott Wave path of Real Estate Investment Trust ($MAA) and explain why it can be telling us that more downside is coming for the Real Estate sector in the near term. Mid-America Apartment Communities (MAA) is a publicly traded real estate investment trust based in Memphis, Tennessee. It invests […]
-
Netflix (NFLX) Looking to Complete 5 Waves Elliott Wave Impulse
Read MoreNetflix (NFLX) is ending 5 waves rally from 3.13.2023 low soon. This article and video look at the Elliott Wave path for the stock.
-
S&P500 ( $SPX ) Elliott Wave Forecasting The Path
Read MoreHello fellow traders. In this article we’re going to take a quick look at the Elliott Wave charts of S&P 500 ( SPX) published in members area of the website. As our members know SPX is showing incomplete structure in the cycle from the January 2022 peak, calling for potential extension lower. Recently we got […]
-
The Best International & Foreign Stocks in 2024
Read MoreList of Best International & Foreign Stocks in 2024 International stocks are an excellent investment option. In fact for long-term investors, they are one of the best options to consider. Here is a list of the top 10 International & Foreign Stocks for investment in 2024: Sr. Company Name Symbol Price (As of ) Market […]
-
$VKTX: Viking Therapeutics Started New Bullish Cycle
Read MoreViking Therapeutics Inc. is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases. Metabolic and rare disease programs include novel selective thyroid receptor-β agonist approach. These and other programs are currently within phases 1, 2 and preclinical. Viking Therapeutics saw IPO back in 2015. Since then, investors can trade it under the […]